E
Emmie de Wit
Researcher at National Institutes of Health
Publications - 134
Citations - 27827
Emmie de Wit is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Virus & Influenza A virus. The author has an hindex of 54, co-authored 120 publications receiving 21709 citations. Previous affiliations of Emmie de Wit include Rocky Mountain Laboratories & Utrecht University.
Papers
More filters
Journal ArticleDOI
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.
Neeltje van Doremalen,Trenton Bushmaker,Dylan H. Morris,Myndi G. Holbrook,Amandine Gamble,Brandi N. Williamson,Azaibi Tamin,Jennifer L Harcourt,Natalie J. Thornburg,Susan I. Gerber,James O. Lloyd-Smith,Emmie de Wit,Vincent J. Munster +12 more
TL;DR: Aerosol and Surface Stability of SARS-CoV-2 In this research letter, investigators report on the stability of Sars-CoVs and the viability of the two virus under experimental conditions.
Journal ArticleDOI
SARS and MERS: recent insights into emerging coronaviruses
TL;DR: The emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 marked the second introduction of a highly pathogenic coronav virus into the human population in the twenty-first century, and the current state of development of measures to combat emerging coronaviruses is discussed.
Journal ArticleDOI
Airborne transmission of influenza A/H5N1 virus between ferrets
Sander Herfst,Eefje J. A. Schrauwen,Martin Linster,Salin Chutinimitkul,Emmie de Wit,Vincent J. Munster,Erin M. Sorrell,Theo M. Bestebroer,David F. Burke,Derek J. Smith,Derek J. Smith,Derek J. Smith,Guus F. Rimmelzwaan,Albert D. M. E. Osterhaus,Ron A. M. Fouchier +14 more
TL;DR: Avian A/H5N1 influenza viruses can acquire the capacity for airborne transmission between mammals without recombination in an intermediate host and therefore constitute a risk for human pandemic influenza.
Journal ArticleDOI
A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment.
TL;DR: A Novel Coronavirus Emerging in China A novel coronavirus, designated as 2019-nCoV, emerged in Wuhan, China, at the end of 2019, although many details of the emergence of this virus remain unknown.
Journal ArticleDOI
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.
Neeltje van Doremalen,Teresa Lambe,Alexandra J. Spencer,Sandra Belij-Rammerstorfer,Jyothi N. Purushotham,Jyothi N. Purushotham,Julia R Port,Victoria A. Avanzato,Trenton Bushmaker,Amy Flaxman,Marta Ulaszewska,Friederike Feldmann,Elizabeth R. Allen,Hannah Sharpe,Jonathan E Schulz,Myndi G. Holbrook,Atsushi Okumura,Kimberly Meade-White,Lizzette Pérez-Pérez,Nick J. Edwards,Daniel B. Wright,Cameron Bissett,Ciaran Gilbride,Brandi N. Williamson,Rebecca Rosenke,Dan Long,Alka Ishwarbhai,Reshma Kailath,Louisa Rose,Susan J. Morris,Claire Powers,Jamie Lovaglio,Patrick W. Hanley,Dana P. Scott,Greg Saturday,Emmie de Wit,Sarah C. Gilbert,Vincent J. Munster +37 more
TL;DR: It is shown that the adenovirus-vector-based vaccine ChAdOx1 nCoV-19, which encodes the spike protein of SARS- CoV-2, is immunogenic in mice and elicites a robust humoral and cell-mediated response.